Metlife Inc. buy Barclays PLC
Summary
This prediction ended on 08.02.26 with a price of €64.69. The prediction for Metlife Inc. disappointed with a performance of -20.04%. Barclays_PLC has a follow-up prediction for Metlife Inc. where he still thinks Metlife Inc. is a Buy. Barclays_PLC has 50% into this predictionMetLife Inc. (Symbol: MET) (WKN: 934623) is a globally renowned insurance, annuities, and employee benefits company, founded in 1868, with its headquarters in New York City. As a leading player in the financial services sector, this Fortune 500 company offers a comprehensive range of products and services, including life insurance, dental and vision coverage, accident and health insurance, retirement and savings solutions, and more. Boasting a diverse clientele, MetLife serves individual customers, SMEs, and large-scale corporations across the globe, with a strong focus on enhancing value for its shareholders, policyholders, and clients. With an underlying commitment to innovation and customer-centric strategies, this publicly traded company (NYSA: MET) has established its presence in more than 40 countries, continuing to expand its horizons in the changing dynamics of global demographics and financial security needs.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Metlife Inc. | -3.814% | -3.814% | -16.895% |
| iShares Core DAX® | -1,10 % | -6,08 % | 3,20 % |
| iShares Nasdaq 100 | 0,33 % | 2,33 % | 20,24 % |
| iShares Nikkei 225® | -1,08 % | -7,99 % | 27,55 % |
| iShares S&P 500 | -0,06 % | 0,88 % | 14,89 % |
Comments by Barclays_PLC for this prediction
In the thread Metlife Inc. diskutieren
In the thread Trading Metlife Inc.